Vitract Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 10

Vitract General Information

Description

Developer of a microbiome technology with personalized nutrition intended to improve digestive health, metabolism, immunity, and mental wellness. The company's technology uses genomic sequencing to identify bacterial groups and metabolites that contribute to your gut health, and brain tests the gut and provides personalized suggestions from the technology to optimize gut health, enabling patients to have a gut microbiome treatment report that health care providers and patients can leverage.

Contact Information

Website
www.vitract.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 838 Walker Road
  • Dover, DE 19904
  • United States
+1 (302)
Primary Industry
Laboratory Services (Healthcare)
Corporate Office
  • 838 Walker Road
  • Dover, DE 19904
  • United States
+1 (302)

Vitract Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitract Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 01-Oct-2025 Completed Profitable
6. Accelerator/Incubator Completed Profitable
5. Angel (individual) Completed Profitable
4. Seed Round 05-May-2023 Completed Profitable
3. Accelerator/Incubator 19-Apr-2022 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Profitable
To view Vitract’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vitract Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitract Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Marathon Fund Venture Capital Minority
Roosh Ventures Venture Capital Minority
Opal Ventures Venture Capital Minority
VHS Ventures Venture Capital Minority
W Fund Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Vitract FAQs

  • When was Vitract founded?

    Vitract was founded in 2022.

  • Where is Vitract headquartered?

    Vitract is headquartered in Dover, DE.

  • What is the size of Vitract?

    Vitract has 10 total employees.

  • What industry is Vitract in?

    Vitract’s primary industry is Laboratory Services (Healthcare).

  • Is Vitract a private or public company?

    Vitract is a Private company.

  • What is Vitract’s current revenue?

    The current revenue for Vitract is .

  • How much funding has Vitract raised over time?

    Vitract has raised $1.12M.

  • Who are Vitract’s investors?

    Marathon Fund, Roosh Ventures, Opal Ventures, VHS Ventures, and W Fund are 5 of 10 investors who have invested in Vitract.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process